Brief: Bioretec Estimates That The European Market Authorization Approval For The Biodegradable Remeos™ Trauma Screw Will Move To Q1, 2024
18/10/2023 18:04
Oct 18 (Reuters) - Bioretec Oy BRETEC.HE :
* BIORETEC ESTIMATES THAT THE APPROVAL OF THE EUROPEAN
MARKET
AUTHORIZATION FOR THE BIODEGRADABLE REMEOS™ TRAUMA SCREW WILL
MOVE TO THE FIRST QUARTER OF 2024
* BIORETEC OY - COMPANY ESTIMATES THAT CE MARK FOR TRAUMA
SCREW
WILL NOT BE OBTAINED DURING END OF 2023, AS PREVIOUSLY EXPECTED
* BIORETEC - REASON FOR CHANGE IS NOTIFIED BODY'S PROLONGED
RESPONSE TIMES AND INSUFFICIENT RESOURCING TO SUPPORT COMPANY'S
CE MARK APPLICATION PROCESS
Source text for Eikon: ID:nWkr15Th9p
Further company coverage: BRETEC.HE
((Reuters.Briefs@thomsonreuters.com;))